GC Therapeutics

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a genome-wide cell programming platform designed to convert patient-derived stem cells into multiple cell types. GC Therapeutics is based in Cambridge, MA and was founded in 2019. Its last known valuation is $135 million. It has raised $74.7 million.

Last price · $/share
—
Implied valuation
$135.0M
Total raised
$74.7M
Last round
—

Who backs GC Therapeutics?

14 investors
InvestorType
Alumni VenturesVenture capital
Andreessen HorowitzVenture capital
Global BrainVenture capital
GaingelsVenture capital
Calm VenturesVenture capital
Harvard Innovation Launch LabOther
Pear (California)Venture capital
Cercano ManagementPE / buyout
Cormorant Asset ManagementVenture capital
Harvard UniversityOther
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

GC Therapeutics investors

14 investors are on record for GC Therapeutics, including Alumni Ventures, Andreessen Horowitz, Global Brain and Gaingels. By type, the record holds 8 venture capital firms and 1 asset manager.

Free account
More of GC Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch GC Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like GC Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View